179 related articles for article (PubMed ID: 36159816)
1. Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma.
Fan Y; Gao Z; Xu J; Wang H; Guo Q; Xue H; Zhao R; Guo X; Li G
Front Immunol; 2022; 13():986615. PubMed ID: 36159816
[TBL] [Abstract][Full Text] [Related]
2. The Non-N
Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
Front Immunol; 2021; 12():809808. PubMed ID: 35154083
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma.
Sun Z; Zhao Y; Wei Y; Ding X; Tan C; Wang C
Front Immunol; 2022; 13():939523. PubMed ID: 36091049
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response.
Zheng H; Wang G; Wang Y; Liu J; Ma G; Du J
iScience; 2023 Oct; 26(10):108055. PubMed ID: 37854704
[TBL] [Abstract][Full Text] [Related]
5. High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis.
Shen GY; Huang RZ; Yang SB; Shen RQ; Gao JL; Zhang Y
BMC Cancer; 2023 Dec; 23(1):1243. PubMed ID: 38104110
[TBL] [Abstract][Full Text] [Related]
6. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
7. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
Front Immunol; 2021; 12():706936. PubMed ID: 34899682
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma.
Liu D; Wan Y; Qu N; Fu Q; Liang C; Zeng L; Yang Y
Front Public Health; 2022; 10():898270. PubMed ID: 35874989
[TBL] [Abstract][Full Text] [Related]
9. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
11. Cell senescence-associated genes predict the malignant characteristics of glioblastoma.
Tan C; Wei Y; Ding X; Han C; Sun Z; Wang C
Cancer Cell Int; 2022 Dec; 22(1):411. PubMed ID: 36527013
[TBL] [Abstract][Full Text] [Related]
12. Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.
Li Q; Yu Q; Ji J; Wang P; Li D
Mol Omics; 2019 Dec; 15(6):406-419. PubMed ID: 31584593
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA small nucleolar RNA host genes: functions and mechanisms in hepatocellular carcinoma.
Li Y; Wang X; Chen S; Wu B; He Y; Du X; Yang X
Mol Biol Rep; 2022 Mar; 49(3):2455-2464. PubMed ID: 34989961
[TBL] [Abstract][Full Text] [Related]
14. The Roles of
Tan AQ; Zheng YF
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553535
[TBL] [Abstract][Full Text] [Related]
15. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
16. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Zhang J; Xiao X; Zhang X; Hua W
J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
[TBL] [Abstract][Full Text] [Related]
17. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma.
Xiong W; Li C; Wan B; Zheng Z; Zhang Y; Wang S; Fan J
Front Immunol; 2022; 13():819080. PubMed ID: 35359993
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding small nucleolar RNA host genes in digestive cancers.
Yang H; Jiang Z; Wang S; Zhao Y; Song X; Xiao Y; Yang S
Cancer Med; 2019 Dec; 8(18):7693-7704. PubMed ID: 31691514
[TBL] [Abstract][Full Text] [Related]
19. Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy.
Ji H; Ba Y; Ma S; Hou K; Mi S; Gao X; Jin J; Gong Q; Liu T; Wang F; Liu Z; Li S; Du J; Hu S
Front Immunol; 2021; 12():729359. PubMed ID: 34566988
[TBL] [Abstract][Full Text] [Related]
20. PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma.
Yi K; Cui X; Liu X; Wang Y; Zhao J; Yang S; Xu C; Yang E; Xiao M; Hong B; Fang C; Kang C; Tan Y; Wang Q
Front Immunol; 2021; 12():802795. PubMed ID: 35069587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
